Assessing tumors in living animals through measurement of urinary β- human chorionic gonadotropin

Nature Medicine

Volumn 6, Issue 6, 2000, Pages 711-714

  Shih, Ie Ming ^a,b   Torrance, Christopher ^a   Sokoll, Lori J ^b   Chan, Daniel W ^a,b   Kinzler, Kenneth W ^a   Vogelstein, Bert ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER DIAGNOSIS; FEMALE; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SHORT SURVEY; URINALYSIS; URINARY EXCRETION;

ANIMALS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GENETIC ENGINEERING; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0034089108     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/76299     Document Type: Short Survey

References (25)

1. Williams, N.N. et al. Growth-factor-independence and invasive properties of colorectal carcinoma cells. Int. J. Cancer 50, 274-280 (1992).
2. Kerbel, R.S. What is the optimal rodent model for anti-tumor drug testing? Cancer Metastasis Rev. 17, 301-304 (1998).
3. Staroselsky, A.N. et al. The use of molecular genetic markers to demonstrate the effect of organ environment on clonal dominance in a human renal-cell carcinoma grown in nude mice. Int. J. Cancer 51, 130-138 (1992).
4. Fidler, I.J., Wilmanns, C., Straroselsky, A., Dong, Z. & Fan, D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev. 13, 209-222 (1994).
5. Killion, J.J., Radinsky, R. & Fidler, I.J. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev. 17, 279-284 (1998).
6. Wilmanns, C., Fan, D., O'Brian, C.A., Bucana, C.D. & Fidler, I.J. Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int. J. Cancer 52, 98-104 (1992).
7. Cole, L.A. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease. J. Reprod. Med. 43, 3-10 (1998).
8. Wu, A.H., Wong, S.S., Waldron, C. & Chan, D.W. Automated quantification of choriogonadotropin: Analytical correlation between serum and urine with creatinine correction. Clin. Chem. 33, 1424-1426 (1987).
9. Shih, I.-M., Mazur, M.T. & Kurman, R.J. in Diagnostic Surgical Pathology (ed. Sternberg, S.S.) 2067-2086 (Williams & Wilkins, New York, 1999).
10. Kanazawa, K. et al. Establishment and characterization of a subline predisposed to pulmonary metastasis from a human gestational choriocarcinoma cell line in nude mice. Acta Obstet. Gynecol. Scand. 68, 429-434 (1989).
11. Takahashi, Y., Ueno, M. & Mai, M. Establishment of a human chorionic gonadotropin-producing human gastric carcinoma in nude mice. J. Surg. Oncol. 48, 96-100 (1991).
12. Kellen, J.A., Kolin, A. & Acevedo, H.F. Effects of antibodies to choriogonadotropin in malignant growth. I. Rat 3230 AC mammary adenocarcinoma. Cancer 49, 2300-2304 (1982).
13. Raikow, R.B. et al. Humoral response of normal and athymic (nude) mice to human choriogonadotropin immunogens. Am. J. Reprod. Immunol. Microbiol. 12, 99-102 (1986).
14. Newman, D.J. & Price, C.P. in Tietz Textbook of Clinical Chemistry (eds. Burtis, C.A. & Ashwood, E.R.) 1204-1270 (W.B. Saunders, Philadelphia, 1999).
15. Culver, K.W. et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552 (1992).
16. Caruso, M. et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA 90, 7024-7028 (1993).
17. Pesce, A.J., Bubel, H.C., DiPersio, L. & Michael, J.G. Human lactic dehydrogenase as a marker for human tumor cells grown in athymic mice. Cancer Res. 37, 1998-2003 (1977).
18. DiPersio, L., Kyriazis, A.P., Michael, J.G. & Pesce, A.J. Monitoring the therapy of human tumor xenografts in nude mice by the use of lactate dehydrogenase. J. Natl. Cancer. Inst. 62, 375-379 (1979).
19. Marini, F.C.III, Nelson, J.A. & Lapeyre, J.N. Assessment of bystander effect potency produced by intratumoral implantation of HSVtk-expressing cells using surrogate marker secretion to monitor tumor growth kinetics. Gene Ther. 2, 655-659 (1995).
20. Yang, M. et al. A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res. 59, 781-786 (1999).
21. Sweeney, T.J. et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad Sci. USA 96, 12044-12049 (1999).
22. MacLaren, D.C. et al. Repetitive, noninvasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6, 785-791 (1999).
23. Galons, J.-P., Altbach, M.I., Paine-Murrieta, G.D., Taylor, C.W. & Gillies, R.J. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by noninvasive diffusion magnetic resonance imaging. Neoplasia 1, 113-117 (1999).
24. Stegman, L.D. et al. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA 96, 9821-9826 (1999).
25. Jacobs, A. et al. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia 1, 154-161 (1999).